Safety of Concurrent Administration of Ozanimod and Serotonergic Antidepressants in Patients with Relapsing Multiple Sclerosis

被引：0

作者：

Naismith, R. T. ^{[1
]}

Cohen, J. A. ^{[2
]}

Bar-Or, A. ^{[3
,4
]}

Comi, G. ^{[5
]}

Selmaj, K. W. ^{[6
,7
]}

Hartung, H. ^{[8
]}

Sheffield, J. K. ^{[9
]}

Minton, N. ^{[9
]}

Gleichmann, M. ^{[9
]}

Liu, H. ^{[9
]}

Riolo, J. ^{[9
]}

Silva, D. ^{[9
]}

Cree, B. A. ^{[10
]}

机构：

[1] Washington Univ, Sch Med, St Louis, MO USA

[2] Cleveland Clin, Mellen Ctr MS Treatment & Res, Cleveland, OH 44106 USA

[3] Univ Penn, Perelman Sch Med, Ctr Neuroinflammat & Expt Therapeut, Philadelphia, PA 19104 USA

[4] Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA

[5] Univ Vita Salute San Raffaele, San Raffaele Sci Inst, Dept Neurol, Milan, Italy

[6] Ctr Neurol, Lodz, Poland

[7] Univ Warmia & Mazury, Dept Neurol, Coll Med, Olsztyn, Poland

[8] Heinrich Heine Univ, Fac Med, Dept Neurol, Dusseldorf, Germany

[9] Bristol Myers Squibb, Princeton, NJ USA

[10] Univ Calif San Francisco, Dept Neurol, Weill Inst Neurosci, San Francisco, CA USA

来源：

MULTIPLE SCLEROSIS JOURNAL | 2021年 / 27卷 / 1_SUPPL期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P080

引用

页码：53 / 54

页数：2

共 50 条

[1] Safety of the Concurrent Administration of Serotonergic Antidepressants and Ozanimod in Patients With Relapsing Multiple Sclerosis
Naismith, R. T.
Cohen, J. A.
Bar-Or, A.
Comi, G.
Selmaj, K. W.
Hartung, H.
Sheffield, J. K.
Krakovich, A.
Cheng, C.
Reardon, J.
Riolo, J. V.
Silva, D.
Cree, B. A.
MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 98 - 99
[2] Safety of the Concurrent Administration of Serotonergic Antidepressants and Ozanimod in Patients With Relapsing Multiple Sclerosis
Naismith, Robert T.
Cohen, Jeffrey A.
Bar-Or, Amit
Comi, Giancarlo
Selmaj, Krzysztof W.
Hartung, Hans-Peter
Sheffield, James K.
Krakovich, Anthony
Cheng, Chun-Yen
Reardon, Jennifer
Riolo, Jon V.
Silva, Diego
Cree, Bruce A. C.
NEUROLOGY, 2023, 100 (17)
[3] Concomitant Administration of Ozanimod and Serotonergic Antidepressants in Patients With Ulcerative Colitis or Relapsing Multiple Sclerosis
Regueiro, Miguel
Siegmund, Britta
Horst, Sara
Moslin, Ryan
Charles, Lorna
Petersen, AnnKatrin
Tatosian, Daniel
Wu, Hsiuanlin
Lawlor, Garrett
Fischer, Monika
D'Haens, Geert
Colombel, Jean-Frederic
INFLAMMATORY BOWEL DISEASES, 2024,
[4] Safety of Concurrent Administration of Ozanimod and Serotonergic Antidepressants in Patients With Ulcerative Colitis
Colombel, Jean-Frederic
Charles, Lorna
Petersen, AnnKatrin
Silver, Michael
Sheffield, James
Minton, Neil
Gleichmann, Marc
Li, Hongjuan
Riolo, Jon
Silva, Diego
Naismith, Robert
Cree, Bruce
Regueiro, Miguel
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S343 - S343
[5] Concurrent administration of serotonergic antidepressants and ozanimod in participants with relapsing multiple sclerosis from the open-label extension DAYBREAK trial
Naismith, Robert T.
Cohen, Jeffrey A.
Bar-Or, Amit
Comi, Giancarlo
Selmaj, Krzysztof W.
Hartung, Hans-Peter
Sheffield, James K.
Krakovich, Anthony
Tatosian, Daniel
Cheng, Chun-Yen
Reardon, Jennifer
Khaychuk, Vadim
Riolo, Jon, V
Silva, Diego
Cree, Bruce A. C.
MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (02) : 177 - 183
[6] Safety of Concurrent Administration of Serotonergic Antidepressants and Ozanimod in Participants With Relapsing Multiple Sclerosis: Final Results From the DAYBREAK Open-label Extension Study
Naismith, Robert
Cohen, Jeffrey
Bar-Or, Amit
Comi, Giancarlo
Selmaj, Krzysztof
Hartung, Hans-Peter
Sheffield, James
Cheng, Chun-Yen
Riolo, Jon
Krakovich, Anthony
Reardon, Jennifer
Cree, Bruce A. C.
MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 1029 - 1030
[7] An Overview of the Efficacy and Safety of Ozanimod for the Treatment of Relapsing Multiple Sclerosis
Fronza, Marzia
Lorefice, Lorena
Frau, Jessica
Cocco, Eleonora
DRUG DESIGN DEVELOPMENT AND THERAPY, 2021, 15 : 1993 - 2004
[8] Comparative safety and efficacy of ozanimod versus fingolimod for relapsing multiple sclerosis
Swallow, Elyse
Patterson-Lomba, Oscar
Yin, Lei
Mehta, Rina
Pelletier, Corey
Kao, David
Sheffield, James K.
Stonehouse, Tim
Signorovitch, James
JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2020, 9 (04) : 275 - 286
[9] Hepatic Safety of Ozanimod in Phase 3 Relapsing Multiple Sclerosis Trials
Comi, Giancarlo
Selmaj, Krzystof
Bar-Or, Amit
Hartung, Hans-Peter
Havrdova, Eva Kubala
Sheffield, James
Minton, Neil
Afsari, Sonia
Liu, Hongjuan
Silva, Diego
Cohen, Jeffrey
NEUROLOGY, 2021, 96 (15)
[10] Ozanimod for the treatment of relapsing remitting multiple sclerosis
Rasche, Ludwig
Paul, Friedemann
EXPERT OPINION ON PHARMACOTHERAPY, 2018, 19 (18) : 2073 - 2086

← 1 2 3 4 5 →